au.\*:("PHAIR, John")
Results 1 to 25 of 92
Selection :
Rheological Analysis of Concentrated Zirconia Pastes with Ethyl Cellulose for Screen Printing SOFC Electrolyte FilmsPHAIR, John W.Journal of the American Ceramic Society. 2008, Vol 91, Num 7, pp 2130-2137, issn 0002-7820, 8 p.Article
Developments and design of novel (non-palladium-based) metal membranes for hydrogen separationPHAIR, John W; DONELSON, Richard.Industrial & engineering chemistry research. 2006, Vol 45, Num 16, pp 5657-5674, issn 0888-5885, 18 p.Article
Leveling and thixotropic characteristics of concentrated zirconia inks for screen-printingPHAIR, John W; LUNDBERG, Mats; KAISER, Andreas et al.Rheologica acta. 2009, Vol 48, Num 2, pp 121-133, issn 0035-4511, 13 p.Article
Clinical challenges of Mycobacterium aviumPHAIR, John P; YOUNG, Lowell S.The American journal of medicine. 1997, Vol 102, Num 5C, issn 0002-9343, 58 p.Serial Issue
Critical drug interactions with agents used for prophylaxis and treatment of Mycobacterium avium complex infectionsBENSON, C. A.The American journal of medicine. 1997, Vol 102, Num 5C, pp 32-36, issn 0002-9343Article
Treatment of Mycobacterium avium in human immunodeficiency virus-infected individualsKOLETAR, S. L.The American journal of medicine. 1997, Vol 102, Num 5C, pp 16-21, issn 0002-9343Article
Registration of clinical trialsLEVY, Jay A; AUTRAN, Brigitte; COUTINHO, Roel et al.AIDS (London). 2005, Vol 19, Num 2, issn 0269-9370, p. 105Article
Microbiology and minimum inhibitory concentration testing for Mycobacterium avium complex prophylaxisINDERLIED, C. B.The American journal of medicine. 1997, Vol 102, Num 5C, pp 2-10, issn 0002-9343Article
Epidemiology of Mycobacterium avium complex diseaseHORSBURGH, C. R.The American journal of medicine. 1997, Vol 102, Num 5C, pp 11-15, issn 0002-9343Article
AIDS 2003: A Year in ReviewAUTRAN, Brigitte; COUNTINHO, Roel; LEVY, Jay et al.AIDS (Supplement). 2003, Vol 17, issn 1350-2840, 133 p., SUP4Serial Issue
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1MARTIN, Maureen P; YING QI; GOEDERT, James J et al.Nature genetics. 2007, Vol 39, Num 6, pp 735-742, issn 1061-4036, 8 p.Article
Lack of associations between HLA class II alleles and resistance to hiv-1 infection among white, non-hispanic homosexual menCHENGLONG LIU; CARRINGTON, Mary; KASLOW, Richard A et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 37, Num 2, pp 1313-1317, issn 1525-4135, 5 p.Article
CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivoBHATTACHARYA, Jayanta; PETERS, Paul J; CLAPHAM, Paul R et al.AIDS (Supplement). 2003, Vol 17, pp S35-S43, issn 1350-2840, SUP4Article
Growing in silence: selected regions and countries with expanding HIV/AIDS epidemicsGHYS, Peter D; SAIDEL, Tobi; HOANG TRAN VU et al.AIDS (Supplement). 2003, Vol 17, pp S45-S50, issn 1350-2840, SUP4Article
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDSXIAOJIANG GAO; NELSON, George W; O' BRIEN, Stephen J et al.The New England journal of medicine. 2001, Vol 344, Num 22, pp 1668-1675, issn 0028-4793Article
Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV type 1 transmission and AIDS disease progressionMODI, William S; LAUTENBERGER, James; WINKLER, Cheryl et al.American journal of human genetics. 2006, Vol 79, Num 1, pp 120-128, issn 0002-9297, 9 p.Article
Persistent GB virus C infection and survival in HIV-infected menWILLIAMS, Carolyn F; KLINZMAN, Donna; HESS, Georg et al.The New England journal of medicine. 2004, Vol 350, Num 10, pp 981-990, issn 0028-4793, 10 p.Article
Virus-host interactions: role of HIV proteins vif, tat, and revSTREBEL, Klaus.AIDS (Supplement). 2003, Vol 17, pp S25-S34, issn 1350-2840, SUP4Article
The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapyJIANMING TANG; KASLOW, Richard A.AIDS (Supplement). 2003, Vol 17, pp S51-S60, issn 1350-2840, SUP4Article
Present status of human HIV vaccine developmentCALAROTA, Sandra A; WEINER, David B.AIDS (Supplement). 2003, Vol 17, pp S73-S84, issn 1350-2840, SUP4Article
Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants, by Dowling et alHOGG, Robert S.AIDS (Supplement). 2003, Vol 17, pp S125-S127, issn 1350-2840, SUP4Article
Randomized, double-blind study in healthy adults to assess the boosting effect of Vaqta or Havrix after a single dose of HavrixCONNOR, Bradley A; PHAIR, John; SACK, David et al.Clinical infectious diseases. 2001, Vol 32, Num 3, pp 396-401, issn 1058-4838Article
Cause-specific mortality among HIV-infected individuals, by CD4+ cell count at HAART initiation, compared with HIV-uninfected individualsWADA, Nikolas; JACOBSON, Lisa P; COHEN, Mardge et al.AIDS (London). 2014, Vol 28, Num 2, pp 257-265, issn 0269-9370, 9 p.Article
Hepatitis B and long-term HIV outcomes in coinfected HAART recipientsHOFFMANN, Christopher J; SEABERG, Eric C; YOUNG, Stephen et al.AIDS (London). 2009, Vol 23, Num 14, pp 1881-1889, issn 0269-9370, 9 p.Article
B cell activation in peripheral blood and lymph nodes during HIV infection, by Zamarchi et alCLERICI, Mario.AIDS (Supplement). 2003, Vol 17, pp S99-S101, issn 1350-2840, SUP4Article